Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
09/03/2014 | EP2771355A1 A MODIFIED EFFECTOR CELL (OR CHIMERIC RECEPTOR) FOR TREATING DISIALOGANGLIOSIDE Gp2-EXPRESSING NEOPLASIA |
09/03/2014 | EP2771354A1 Method for preparing human factor h |
09/03/2014 | EP2771353A1 Polypeptides having xylanase activity and polynucleotides encoding same |
09/03/2014 | EP2771352A1 Vaccine |
09/03/2014 | EP2771349A2 Bioinformatic processes for determination of peptide binding |
09/03/2014 | EP2771036A2 Cystic fibrosis treatment |
09/03/2014 | EP2771026A1 Ultra-concentrated rapid-acting insulin analogue formulations |
09/03/2014 | EP2770822A1 Transgenic mice expressing chimeric major histocompatibility complex (mhc) class ii molecules |
09/02/2014 | US8822789 Inbred corn line BB86 |
09/02/2014 | US8822788 Maize variety hybrid X13B640 |
09/02/2014 | US8822764 Soybean variety A1026201 |
09/02/2014 | US8822761 Genes for enhancing nitrogen utilization efficiency in crop plants |
09/02/2014 | US8822758 Gene capable of increasing the production of plant biomass and method for using the same |
09/02/2014 | US8822757 Nucleic acid sequences encoding transcription factors regulating nicotine alkaloid biosynthesis and their use in modifying plant metabolism |
09/02/2014 | US8822665 Neuron generation, regeneration and protection |
09/02/2014 | US8822656 Manufacture of factor H (FH) and FH-derivatives from plasma |
09/02/2014 | US8822654 Mutated antithrombins, a process for preparing the same and their use as drugs |
09/02/2014 | US8822650 Method for the mass production of immunoglobulin constant region |
09/02/2014 | US8822643 Process for the preparation of a virus-inactivated FV concentrate starting from human plasma, scalable to industrial level |
09/02/2014 | US8822642 Dimeric fusion proteins and related compositions and methods |
09/02/2014 | US8822641 Method for detecting and removing endotoxin |
09/02/2014 | US8822640 Tetrameric streptavidin mutein with reversible biotin binding capability |
09/02/2014 | US8822637 Somatostatin analogues |
09/02/2014 | US8822636 Peptides for activation and inhibition of δPKC |
09/02/2014 | US8822551 Implantation material comprising biocompatible polymer |
09/02/2014 | US8822442 Somatostatin-dopamine chimeric analogs |
09/02/2014 | US8822440 Inhibiting cyclin D polypeptides |
09/02/2014 | US8822427 Methods and compositions to protect aquatic invertebrates from disease |
09/02/2014 | US8822421 E2F as a target of hormone refractory prostate cancer |
09/02/2014 | US8822417 Albumin variants |
09/02/2014 | US8822412 Charged nutritive proteins and methods |
09/02/2014 | US8822411 Truncated activin type II receptor and methods of use |
09/02/2014 | US8822409 Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ARDS) and clinical disorders associated with therewith |
09/02/2014 | US8822196 Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer |
09/02/2014 | US8822182 Chimeric antigen-specific T cell-activating polypeptides |
09/02/2014 | US8822181 Production of proteins |
09/02/2014 | US8822178 Sweetener preparations and methods of use |
09/02/2014 | US8822165 Method for producing cAMP using chimeric olfactory receptor |
09/02/2014 | US8822163 Method for measuring β-glucan, and β-glucan-binding protein for use in the method |
09/02/2014 | US8822162 Cyanochrome fluorophores |
09/02/2014 | US8822160 Molecular adaptors |
09/02/2014 | US8822145 Identification of POLD2 sequences |
09/02/2014 | US8821955 Protein concentrates and isolates, and processes for the production thereof |
09/02/2014 | US8821917 Biopolymeric membranes |
09/02/2014 | US8821897 Viral adjuvants |
09/02/2014 | US8821895 Streptococcus pyogenes antigens and corresponding DNA fragments |
09/02/2014 | US8821894 Compositions and methods related to protein A (SpA) variants |
09/02/2014 | US8821885 Immunogenic compositions and methods |
09/02/2014 | US8821883 Method of treating B cell cancers by administering truncated BAFF receptors |
09/02/2014 | US8821873 Treatment of diffuse large-cell lymphoma with anti-CD20 antibody |
09/02/2014 | US8821864 Compounds and methods useful for detection and treatment of cancer |
09/02/2014 | US8821858 Lyophilized platelet rich plasma for the use in wound healing (chronic or acute) and bone or tissue grafts or repair |
09/02/2014 | US8821857 Human placental collagen compositions and methods of making and using the same |
09/02/2014 | US8821856 Method of targeted gene delivery using viral vectors |
09/02/2014 | CA2736974C Tumour-associated peptides that bind to mhc molecules |
09/02/2014 | CA2594918C Dr5 antibodies and uses thereof |
09/02/2014 | CA2575387C Novel peptide and pharmaceutical composition containing said peptide |
09/02/2014 | CA2466937C Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation processes and immunogene compositions containing such an antigen |
09/02/2014 | CA2438315C Attenuated pasteurellaceae bacteria and an anti-bacterial vaccine prepared therefrom |
08/28/2014 | WO2014130723A1 Methods and compositions for treatment of pompe disease |
08/28/2014 | WO2014130722A1 Methods and compositions for treatment of forbes-cori disease |
08/28/2014 | WO2014130671A1 Mice expressing humanized t-cell co-receptors |
08/28/2014 | WO2014130667A1 Mice expressing humanized major histocompatibility complex |
08/28/2014 | WO2014130659A1 Chimeric fibroblast growth factor 23 proteins and methods of use |
08/28/2014 | WO2014130635A1 Effective targeting of primary human leukemia using anti-cd123 chimeric antigen receptor engineered t cells |
08/28/2014 | WO2014130529A1 In ovo administration of growth factors for improving poultry performance |
08/28/2014 | WO2014129876A1 Method of isolating and purifying fusion protein comprising factor vii |
08/28/2014 | WO2014128555A2 Vaccine |
08/28/2014 | WO2014127835A1 Plant-derived resistance gene |
08/28/2014 | WO2014127798A1 Functional peptides for obesity disorders |
08/28/2014 | WO2014127744A1 Compositions and methods involving genes encoding wrkytranscription factors |
08/28/2014 | WO2014127478A1 Vaccine composition |
08/28/2014 | WO2014127414A1 Manipulation of self-incompatibility in plants |
08/28/2014 | WO2014106001A3 Dual specific binding proteins having a receptor sequence |
08/28/2014 | WO2014093505A3 Acp-mediated production of fatty acid derivatives |
08/28/2014 | WO2014085365A3 Compositions and methods for treatment of metabolic disorders and diseases |
08/28/2014 | WO2014083060A3 Pseudomonas antigens and antigen combinations |
08/28/2014 | WO2014071358A3 Novel ntrk1 fusion molecules and uses thereof |
08/28/2014 | WO2014071344A3 Method of isolating synagis® in the absence of benzonase |
08/28/2014 | WO2014059384A3 ICAM-1 TARGETING ELPs |
08/28/2014 | WO2014018929A3 Foaming agent for use in personal care products and industrial products |
08/28/2014 | WO2014018923A3 Emulsifying agent for use in personal care products and industrial products |
08/28/2014 | US20140245491 Axmi218, axmi219, axmi220, axmi226, axmi227, axmi228, axmi229, axmi230 and axmi231 delta-endotoxin genes and methods for their use |
08/28/2014 | US20140243510 Methods for purifying erythropoietin analogs having lower isoelectric point |
08/28/2014 | US20140243503 Fgf21 mutants and uses thereof |
08/28/2014 | US20140243502 Anticoagulation agent and uses thereof |
08/28/2014 | US20140243499 Peptide derivatives and use thereof as carriers for molecules in the form of conjugates |
08/28/2014 | US20140243498 Method for purification of cleaved pro-insulin |
08/28/2014 | US20140243399 Engineered nucleic acids and methods of use thereof |
08/28/2014 | US20140243398 Irs modulators |
08/28/2014 | US20140243277 Water Soluble Membrane Proteins and Methods for the Preparation and Use Thereof |
08/28/2014 | US20140243272 Compound and method for treatment of alzheimer's disease |
08/28/2014 | US20140243269 Method of effecting neuroprotection using soluble neuregulin isoforms |
08/28/2014 | US20140243268 ERBB2 Peptides |
08/28/2014 | US20140243266 Uses and methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseases |
08/28/2014 | US20140243265 Antibodies to modified human igf-1/e peptides |
08/28/2014 | US20140243264 Methods of treatment for retinal diseases |
08/28/2014 | US20140243260 Chimeric fibroblast growth factor 23 proteins and methods of use |
08/28/2014 | US20140243256 Arenavirus inhibiting peptides and uses therefor |
08/28/2014 | US20140243215 Method for diagnosing renal diseases or predispositions |